Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.
about
Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells.Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.Correlated mass spectrometry and confocal microscopy imaging verifies the dual-targeting action of an organoruthenium anticancer complex.Metal NHC Complexes with Naphthalimide Ligands as DNA-Interacting Antiproliferative Agents.
P2860
Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Complexation with organometall ...... inazolines inducing apoptosis.
@en
Complexation with organometall ...... inazolines inducing apoptosis.
@nl
type
label
Complexation with organometall ...... inazolines inducing apoptosis.
@en
Complexation with organometall ...... inazolines inducing apoptosis.
@nl
prefLabel
Complexation with organometall ...... inazolines inducing apoptosis.
@en
Complexation with organometall ...... inazolines inducing apoptosis.
@nl
P2093
P2860
P50
P356
P1476
Complexation with organometall ...... uinazolines inducing apoptosis
@en
P2093
Xiuli Wang
P2860
P304
10224-10226
P356
10.1039/C3CC43000F
P407
P577
2013-11-01T00:00:00Z